Timing, signal strength, tissue type, exposure to infections, microbiome, genetic and epigenetic modifiers may influence the phenotypic variation observed in patients with pathogenic mutations in key NF-κB components, including RELA (7). This evidence concerns the gene NFKB1 and infection.